Buffalo, NY, United States of America

Daniel Bailey


Average Co-Inventor Count = 13.0

ph-index = 1


Company Filing History:


Years Active: 2016

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Daniel Bailey

Introduction

Daniel Bailey is a notable inventor based in Buffalo, NY (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of methods for preparing compounds that are useful in treating central nervous system disorders. His work exemplifies the intersection of innovation and practical application in the medical field.

Latest Patents

Daniel Bailey holds a patent for "Methods for the preparation of 5-[2-[7-(trifluoromethyl)-5-[4-(trifluoromethyl)phenyl]pyrazolo[1,5-A]pyrimidin-3-yl]ethynyl]-2-pyridinamine." This invention provides methods for preparing compound A, which is beneficial for the treatment of depression and other CNS disorders. The methods outlined in his patent are designed for large-scale production in manufacturing facilities, showcasing his focus on practical applications of his inventions.

Career Highlights

Bailey is currently employed at Hoffmann-La Roche Inc., a leading company in the pharmaceutical industry. His role there allows him to further his research and development efforts, contributing to advancements in medical treatments. His dedication to innovation is evident in his work and the impact it has on healthcare.

Collaborations

Daniel Bailey collaborates with talented professionals in his field, including coworkers Stephan Bachmann and Jodie Brice. These collaborations enhance the research environment and foster the exchange of ideas, which is crucial for innovation.

Conclusion

Daniel Bailey's contributions to the field of pharmaceuticals through his innovative patent and work at Hoffmann-La Roche Inc. highlight the importance of research and collaboration in developing effective treatments for CNS disorders. His efforts continue to make a significant impact in the medical community.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…